Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N3NL
|
|||
| Former ID |
DNC000151
|
|||
| Drug Name |
Acriflavine
|
|||
| Synonyms |
Acriflavine; Xanthacridinum; Euflavine; Pantonsiletten; Flavinetten; Assiflavine; Choliflavin; Bialflavina; Vetaflavin; Buroflavin; Tolivalin; Isravin; Diacrid; Zoriflavin; Trachosept; Gonacin; Flavisept; Flavioform; Bovoflavin; Mediflavin; Bioacridin; Angiflan; Tripla-etilo; Glyco-flavine; Acriflavine neutral; Acriflavine [NF]; Caswell No. 008; Euflavin; Flavacridinum hydrochloricum; Trypaflavine Neutral; CCRIS 5617; UNII-1T3A50395T; EPA Pesticide Chemical Code 000501; Acridinium, 3,6-diamino-10-methyl-, chloride, mixt. with 3,6-acridined
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H25ClN6
|
|||
| Canonical SMILES |
C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N)N.C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N.[Cl-]
|
|||
| InChI |
1S/C14H13N3.C13H11N3.ClH/c1-17-13-7-11(15)4-2-9(13)6-10-3-5-12(16)8-14(10)17;14-10-3-1-8-5-9-2-4-11(15)7-13(9)16-12(8)6-10;/h2-8H,1H3,(H3,15,16);1-7H,14-15H2;1H
|
|||
| InChIKey |
PEJLNXHANOHNSU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 8048-52-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
13450, 3135503, 10299200, 14785064, 24845181, 24891319, 36886484, 49864492, 53277397, 57404282, 84943632, 87561825, 88838065, 104629162, 117371316, 125299290, 125332607, 125767616, 134339666, 134990625, 135253628, 135359609, 137251313, 144204890, 152041943, 162092604, 162180813, 170465670, 175272037, 176263762, 179316724, 184568506, 184811887, 226457120, 241154022, 242573685, 251886850
|
|||
| SuperDrug ATC ID |
R02AA13
|
|||
| SuperDrug CAS ID |
cas=000086408
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Integrase (HIV IN) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Why have ten or so nontoxic, retrovirus integrase inhibitors not been made available for AIDS treatment. Biomed Pharmacother. 1999 Dec;53(10):484-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.